Back to search

Cambridge Neurotech Ltd

08783030

active
Private Limited Company
england wales
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)

Details

64 HIGH STREET, CAMBRIDGE, CB25 0LD
Incorporated 20/11/2013

Compliance

Last accounts

30/11/2024

total exemption full

Next accounts due

31/08/2026

On track

Confirmation statement

Last: 28/10/2025

Due 11/11/2026

On track

Industry

72110
Research and experimental development on biotechnology
74909
Other professional, scientific and technical activities

Officers

Dr Tahl Holtzman

director · Since 20/11/2013

FOUNDER AND DIRECTOR

BRITISH · ENGLAND · Age 48

Ms Sarah-Jane Mcewan

director · Since 01/12/2021

ECONOMIST

BRITISH · ENGLAND · Age 51

Persons with Significant Control

Dr Tahl Holtzman

75–100% shares

British · England · Age 48

64, High Street, Cambridge, CB25 0LD

Notified 06/04/2016

CompanyRankvs 160+ SIC 72110 peers
82

Financial strength95th percentile among SIC peers · 24/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 20.55× · 20/20
Longevity13 years trading (max 15) · 13/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity13/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/11/2024

Net Worth

£2.4M

Balance sheet strength

Cash

£1.4M

Cash in the bank

Net Current Assets

£2.3M

Working capital

Current Assets

£2.5M

Current Liabilities

£120k

Fixed Assets

£8k

Debtors

£757k

2avg. employees
Prepared with VT Final Accounts

EstimatesDerived

YearCurrent RatioImplied Profit
202420.55+£200k
20238.25+£491k
20215.22+£546k
20204.28+£244k
20199.87+£367k
201811.78

Derived from filed accounts. Not audited figures.